Ypsilon Therapeutics

Ypsilon Therapeutics is a startup. Brouky classifies it under Healthcare & Life Sciences.

Ypsilon Therapeutics develops next-generation cancer therapies including T-cell receptor mimic antibodies and bispecific T-cell engagers targeting solid tumors such as triple-negative breast cancer and non-small-cell lung cancer while sparing healthy tissue.